Anna E. Czapar
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
- Biotechnology top 5%
- Transgenic Plants and Applications
Papers in
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 11
-
- Transgenic Plants and Applications 2
- Co-authors
- Nicole F. Steinmetz (15 shared papers)Sourabh Shukla (3 shared papers)Ravi B. Patel (2 shared papers)Stephen J. Lippard (2 shared papers)Andrzej S. Pitek (3 shared papers)Imogen A. Riddell (1 shared paper)Yao‐Rong Zheng (1 shared paper)Samuel G. Awuah (1 shared paper)
- Journals
- Biomacromolecules (1 paper)Journal of Controlled Release (1 paper)Bioconjugate Chemistry (1 paper)ACS Omega (1 paper)ACS Nano (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Anna E. Czapar
18 papers receiving 929 citations
Peers
Comparison fields: 5 of 63
- Biomaterials 471
- Biotechnology 131
- Immunology 151
- Molecular Medicine 29
- Biomedical Engineering 127
Countries citing papers authored by Anna E. Czapar
This map shows the geographic impact of Anna E. Czapar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna E. Czapar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna E. Czapar more than expected).
Fields of papers citing papers by Anna E. Czapar
This network shows the impact of papers produced by Anna E. Czapar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna E. Czapar. The network helps show where Anna E. Czapar may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna E. Czapar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 149 | |
| 2 | 2016 | 103 | |
| 3 | 2017 | 103 | |
| 4 | 2016 | 99 | |
| 5 | 2016 | 75 | |
| 6 | 2018 | 73 | |
| 7 | 2017 | 67 | |
| 8 | 2018 | 61 | |
| 9 | 2014 | 55 | |
| 10 | 2018 | 40 | |
| 11 | 2012 | 32 | |
| 12 | 2018 | 32 | |
| 13 | 2016 | 30 | |
| 14 | 2018 | 15 | |
| 15 | 2021 | 3 | |
| 16 | 2015 | 2 | |
| 17 | The in vivo fates of plant viral nanoparticles camouflaged using self-proteins: overcoming immune recognition | 2018 | 1 |
| 18 | 2024 | 1 | |
| 19 | 2025 | 0 |
About Anna E. Czapar
Anna E. Czapar is a scholar working on Biomaterials, Biotechnology, Immunology, Oncology and Microbiology, having authored 19 papers that have together received 941 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Immunotherapy and Immune Responses (3 papers), Nanoplatforms for cancer theranostics (2 papers), Transgenic Plants and Applications (2 papers), Metal complexes synthesis and properties (2 papers), Pregnancy and preeclampsia studies (1 paper), Bacteriophages and microbial interactions (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Biomaterials (471 citations), Biotechnology (131 citations), Immunology (151 citations), Molecular Medicine (29 citations) and Biomedical Engineering (127 citations). Anna E. Czapar has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Nicole F. Steinmetz, Sourabh Shukla, Ravi B. Patel, Stephen J. Lippard, Andrzej S. Pitek, Imogen A. Riddell, Yao‐Rong Zheng, Samuel G. Awuah, Michael A. Bruckman and Herdis Bludau. Their work appears in journals such as Biomacromolecules, Journal of Controlled Release, Bioconjugate Chemistry, ACS Omega and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.